A system for cosmetically treating a patient's skin or body with one or more EMS coils and/or RF electrodes mounted on a planar holder; a hydrogel containing gel pad, the gel pad being positionable between the holder and the skin tissue; wherein the gel pad being of a material that is biocompatible and conducts RF and/or EMS energy when EMS energy is applied from the one or more EMS coils; a programmable controller to activate the one or more EMS coils; the programmable controller, after the planar holder is applied to the skin tissue, being configured to activate one or more of the plurality of EMS coils to provide treatment in the form of stimulation to the skin tissue.

Transducer arrays for applying alternating electric fields (e.g., tumor treating fields a.k.a. TTFields) to a subject's body typically include a plurality of capacitively coupled electrode elements. Often, certain electrode elements on a given array tend to run hotter than other electrode elements. For example, in many anatomical contexts, the corner elements of the transducer array tend to run hotter than the non-corner elements. The spread of operating temperatures between the electrode elements that tend to run hotter and the other electrode elements can be reduced by wiring a capacitor in series with those electrode elements that tend to run hotter (e.g., the corner elements).

Applicators, systems, and methods for delivering electrical energy to a target treatment region with large area surface electrodes are disclosed. In one example, a system may include a housing, a pulse generator, and a treatment applicator coupled to the pulse generator and configured to deliver sub-microsecond high-voltage electric pulses from the pulse generator. The treatment applicator may include a first and second electrodes coupled to a substrate, where the first and second electrodes are configured to provide a uniform gap between edges of the first and second electrodes.

Methods of treating cancer are provided. In some instances, the method comprises applying alternating electric fields to the abdomen of the subject at a frequency of 100 to 500 kHz, administering a checkpoint inhibitor to the subject, and administering systemic cancer therapy to the subject. In some instances, the cancer is pancreatic ductal adenocarcinoma.

A transducer array including a conductive layer and a conductive gel layer is described. The conductive layer has one or more electrode element. The one or more electrode element is configured to receive electrical signals from an electric field generator producing an electric signal as a Tumor Treating Field. The conductive gel layer overlaps the one or more electrode element of the conductive layer. The conductive gel layer has a first region and a second region. The first region has a first resistivity and the second region having a second resistivity with the first resistivity being different from the second resistivity.

Improved hydrogel configurations for use with a TTField-generating system is disclosed. Also disclosed are kits containing the improved hydrogel configurations and methods of producing and using the improved hydrogel configurations.

A method for using beauty instrument with mask is provided. The method comprises providing a beauty instrument with mask comprising a flexible mask and a controller, applying the flexible mask of on a user's face, and turning on the controller and selecting a function button on the controller, inputting a current to a plurality of functional layers in the flexible mask, and stimulating face skin with the current.

The present disclosure is in the field of sleep and respiratory care. In particular, the present disclosure provides means and methods for decreasing the respiratory effort of a sleeping subject. The present disclosure also provides means and methods for treating the snoring of a sleeping subject.

An electrode for stimulating a neuromuscular response includes a backing layer, an electrode layer, and a hydrogel layer, and an electrode cable configured to provide an electrical signal to the electrode. The electrode is divided into a first removable portion including a first removable activation area, a second removable portion including a second removable activation area, and a main body including a main activation area, the first removable portion is configured to separate from the second removable portion and the main body by a first perforation, and the second removable portion is configured to separate from the main body by a second perforation.

A patient-worn arrhythmia monitoring and treatment device includes a pair of therapy electrodes and at least one pair of sensing electrodes disposed proximate to the skin and configured to continually sense at least one ECG signal of the patient over an extended period of time. The device includes a therapy delivery circuit coupled to the pair of therapy electrodes and configured to deliver one or more therapeutic pulses. A controller coupled to therapy delivery circuit is configured to analyze the at least one ECG signal and detect one or more treatable arrhythmias and cause the therapy delivery circuit to deliver the one or more therapeutic pulses to the patient. At least one of the one or more therapeutic pulses is formed as a biphasic waveform delivering within 15 percent of 360 J of energy to a patient body having a transthoracic impedance from about 20 to about 200 ohms.